4-Benzyl-2-Hydroxymorpholin-3-One Bulk Price Global Manufacturer Insights
- Technical Specification: Achieve ≥98.0% purity (GC) with a melting point of 136°C for consistent reaction outcomes.
- Procurement Strategy: Transition from catalog rates to factory direct pricing for significant cost reductions on scale-up production.
- Supply Chain Security: Partner with a verified global manufacturer for reliable bulk supply and comprehensive documentation.
In the pharmaceutical intermediate sector, securing a reliable supply chain for critical building blocks is paramount. 4-Benzyl-2-hydroxymorpholin-3-one serves as a vital precursor in the synthesis of antiemetic agents, specifically acting as a key Fosaprepitant intermediate. For process chemists and procurement managers, understanding the disparity between small-pack catalog pricing and industrial bulk rates is essential for optimizing manufacturing costs. This analysis details the technical specifications, pricing structures, and strategic advantages of sourcing directly from a dedicated production facility.
Bulk Pricing Tiers Versus Small Pack Catalog Rates
The cost structure for fine chemicals varies drastically based on volume. Catalog suppliers typically package materials in gram quantities for laboratory research, inflating the price per kilogram to cover handling, labeling, and distribution overhead. In contrast, industrial procurement focuses on metric ton scales where the unit cost decreases exponentially. When evaluating the bulk price for 4-Benzyl-2-hydroxymorpholin-3-one, buyers must account for the elimination of secondary packaging and the efficiencies of large-batch processing.
Small-scale suppliers often list prices that are unsustainable for commercial manufacturing. For instance, purchasing grams at a premium rate might be feasible for initial route scouting, but it fails during technology transfer. A dedicated global manufacturer optimizes the manufacturing process to reduce solvent usage and energy consumption per unit. This efficiency is passed down to the buyer in the form of tiered pricing models. Companies aiming for commercial viability must negotiate contracts that reflect true production volumes rather than retail markup.
Technical Specifications and Quality Consistency
Consistency in physical and chemical properties is non-negotiable for regulatory compliance. The target material typically presents as a white crystalline powder with a defined melting point of 136°C. Maintaining industrial purity levels at or above 98.0% (GC) ensures that downstream reactions proceed with high yields and minimal impurity profiles. Variations in purity can lead to failed batches in subsequent synthesis steps, costing significantly more than the initial savings on cheaper, lower-grade material.
Below is a comparison of standard technical parameters expected from a tier-one supplier:
| Parameter | Specification | Test Method |
|---|---|---|
| Chemical Name | 4-Benzyl-2-hydroxymorpholin-3-one | NMR/MS |
| CAS Registry Number | 287930-73-8 | Database Verification |
| Molecular Formula | C11H13NO3 | Calculated |
| Molecular Weight | 207.23 g/mol | Calculated |
| Purity | ≥98.0% | GC/HPLC |
| Melting Point | 136°C | DSC/Capillary |
| Appearance | White Crystalline Powder | Visual |
When analyzing the molecular structure of C11H13NO3, buyers should ensure that the supplier provides detailed impurity profiles. This level of transparency is standard for factory direct engagements but often lacking in distributed catalog models.
Global Manufacturer Direct Cost Savings Analysis
Engaging directly with a production site removes multiple layers of intermediaries. Distributors often add margins ranging from 20% to 50% to cover their logistics and storage costs. By contracting with NINGBO INNO PHARMCHEM CO.,LTD., purchasers access the source of production. This direct line of communication facilitates better technical support regarding the synthesis route and storage conditions.
Cost savings are not limited to the unit price. Direct manufacturers can customize packaging to suit specific logistical needs, such as drum sizes or bulk bags, which reduces waste and handling time upon receipt. Furthermore, a dedicated manufacturer can align production schedules with the buyer's demand forecasts, reducing inventory holding costs. This synergy is crucial for maintaining lean operations in pharmaceutical manufacturing.
Scale-Up Production Capabilities
Transitioning from kilogram to ton-scale requires robust infrastructure. A capable partner must demonstrate proven scale-up production capabilities without compromising quality. This involves having redundant reactor systems, validated cleaning processes, and sufficient warehouse capacity. When a supplier can guarantee continuous supply despite market fluctuations, the total cost of ownership decreases significantly.
Reliability also extends to documentation. Regulatory bodies require comprehensive data packages. Sourcing from a reputable entity ensures that every batch is accompanied by a valid COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet). These documents are essential for filing regulatory dossiers and ensuring worker safety during handling.
Requesting Custom Quotes for Large Volume Orders
To obtain accurate pricing, procurement teams should provide detailed requirements beyond simple quantity. Information regarding desired purity levels, packaging specifications, and delivery timelines allows the manufacturer to generate a precise quote. Custom synthesis options may also be available if specific impurity profiles or isotopic labeling are required for clinical trials.
When initiating contact, specify the intended application, such as use as a morpholinone derivative in generic drug production. This context helps the technical team recommend the most cost-effective grade. For long-term contracts, manufacturers often offer locked-in pricing to protect against raw material volatility. This stability is invaluable for financial planning and product costing.
Ultimately, the decision to source 4-Benzyl-2-hydroxymorpholin-3-one should be driven by a combination of technical capability and commercial viability. NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support global clients with high-quality intermediates and transparent pricing structures. By prioritizing direct manufacturer relationships, companies can secure the supply chain integrity necessary for successful commercialization.
Conclusion
Optimizing the procurement of critical intermediates requires a shift from retail thinking to industrial strategy. Understanding the technical nuances, such as melting point consistency and purity thresholds, ensures product quality. Simultaneously, leveraging bulk pricing tiers and direct manufacturer relationships drives down costs. For organizations seeking a partner for custom synthesis and bulk supply, establishing a direct line to a proven production facility is the most effective path forward.